Carbonite Closes Acquisition of Webroot

Related Posts

13Nov

Zylö Receives $225,000 NIH Grant to Further Develop Nitric-Oxide-Releasing Z-pods™ to Treat Erectile Dysfunction

Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, has been awarded a $225,000 Small Business Technology Transfer... read more
11Oct

Fermented Protein Could Be the Path to Sustainable Aquaculture

In 2013, Larry Feinberg and Chris Marx founded KnipBio with one goal in mind: sustainability. It’s an area Feinberg has... read more
08Jul

Employers Boost Use Of Digital Tools To Stamp Out Student Debt

The student debt crisis is something of a ticking time bomb, and employers are increasingly stepping up by offering digital... read more
29Jun

Paul Gudonis (CEO Of Myomo)

Paul Gudonis (CEO Of Myomo) by The Financial Exchange transcript. Read more >> read more
01Feb

Benefit’s Automated Kiosk To Debut in Canada

Benefit first partnered with ZoomSystems in 2013 to create Glam up & away. ZoomSystems is the global leader in high-end... read more
12Mar

Akston Biosciences’ AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility

Akston Biosciences, dedicated to accelerating the next revolution in Animal Health, announced the publication in Frontiers in Immunology of a... read more
21Aug

Myomo® Receives First Australian Insurance Authorization for MyoPro™

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,... read more
05Jul

Boone County parents try to raise money to give special glasses to child

Ellie Leden’s parents hope people will listen to their child’s plight and understand how much a new pair of glasses... read more
13Sep

Wasabi Technologies Joins Forces with Grass Valley as Cloud Storage Provider of Choice to Enable Streamlined Media Archiving for Live Events

Wasabi Technologies, the hot cloud storage company, today announced that Grass Valley, a leading media technology provider for the media... read more
30Jan

Corbus Pharmaceuticals Announces Agreement with FDA on Phase 2b Cystic Fibrosis Study Design with Pulmonary Exacerbations as Sole Primary Endpoint

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious... read more